申请人:Technische Universität München
公开号:EP4023250A1
公开(公告)日:2022-07-06
The present disclosure relates to compounds of Formula (1a), (1b), (1c) or (1d):
and pharmaceutically acceptable salts thereof, wherein X, Z, L, CM and R1 are defined herein, and their use as cancer diagnostic or imaging agents.
本公开涉及以下式子的化合物(1a)、(1b)、(1c)或(1d):以及其药学上可接受的盐,其中X、Z、L、CM和R1在此定义,并且它们作为癌症诊断或成像剂的用途。